Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 7.9B | 7.3B | 6.8B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 528M | 823M | 415M | 409M |
Other operating expenses | 418M | 274M | 438M | 428M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.4B | 3.3B | 3.6B | 3.1B |
Tax provision | 914M | 850M | 1.2B | 702M |
Net income | 2.5B | 2.4B | 2.5B | 2.4B |
Basic EPS | 2.0 | — | 2.0 | 1.9 |
Diluted EPS | 2.0 | — | 2.0 | 1.9 |
Basic average shares | 1.3B | — | 1.3B | 1.3B |
Diluted average shares | 1.3B | — | 1.3B | 1.3B |
EBITDA | — | — | — | — |
Net income from continuing op. | 3.4B | 3.3B | 3.6B | 3.1B |
Minority interests | 0 | 1M | -2M | 0 |
Preferred stock dividends | — | — | — | — |